A Novel In Situ Dendritic Cell Vaccine Triggered by Rose Bengal Enhances Adaptive Antitumour Immunity

Dendritic cell- (DC-) based vaccination has emerged as a promising antitumour immunotherapy. However, overcoming immune tolerance and immunosuppression in the tumour microenvironment (TME) is still a great challenge. Recent studies have shown that Rose Bengal (RB) can effectively induce immunogenic...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Lanlin, Du, Jiangyuan, Song, Qian, Zhang, Chufan, Wu, Xianghua
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8824725/
https://www.ncbi.nlm.nih.gov/pubmed/35155685
http://dx.doi.org/10.1155/2022/1178874

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8824725/
https://www.ncbi.nlm.nih.gov/pubmed/35155685
http://dx.doi.org/10.1155/2022/1178874

Ejemplares similares